10:50 18.01.2017

Ukrainian medical institutions refuse taking child cancer medicines procured by Crown Agents

2 min read

KYIV. Jan 18 (Interfax-Ukraine) – Ukrainian medical institutions refuse taking child cancer medicines procured by Britain's Crown Agents as they expire in a short term, Chief of the Pediatric Hematology and Bone Marrow Transplantation Center Svitlana Donska has said.

"Now medical departments in the country are refusing to take these medicines, as they are to use their full quota in next three months," she said at a press conference at Interfax-Ukraine.

Donska said that Crown Agents supplied child cancer medicines with the expiration term that is shorter than it is set in the technical specifications – 15 months. The agency supplied medicines that expire in six or eight months.

She also said that some medicines failed to meet the ordered pharmaceutical dosage form. Phosphomycinum antibiotic was supplied in the pouche dosage form instead of vials for intravenous injections. She said that the dosage did not suit the ordered dosage.

The medicines with the improper pharmaceutical dosage form were returned to Crown Agents. The agency is replacing them by vials.

Another medicine procured to treat child cancer is meant to treat rheumatoid arthritis.

Donska also said that working groups that draw up lists of medicines required in all segments were dissolved.

"Now we would not have a working group that has at least the advisory right to offer the range of effective medicines and medical products. Now we have a large expert group responsible for all segments," she said.

AD
AD
AD
AD